Compare Merck Tbk. (MERK) vs Salim Ivomas Pratama Tbk. (SIMP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck Tbk. vs Salim Ivomas Pratama Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Salim Ivomas Pratama Tbk. trades at Rp555 (market cap 8.45T, 6.93M 24h volume). The key difference: Salim Ivomas Pratama Tbk. is far larger — about 5× Merck Tbk.'s market cap, and Salim Ivomas Pratama Tbk. is more actively traded (6.93M versus 37.6K). Which is the better fit depends on your goals.
| MERK | SIMP | |
|---|---|---|
Market Cap | 1.7T | 8.45T |
Volume | 37.6K | 6.93M |
Lot | 376 | 69.29K |
Turnover | 144.47M | 3.81B |
Average Price | 3,842.23 | 549.27 |
Value | 144.47M | 3.81B |
Indicative Equilibrium Price | 3,840 | 555 |
Indicative Equilibrium Volume | 7 | 2.29K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →About Salim Ivomas Pratama Tbk.
PT Salim Ivomas Pratama Tbk (the company) was established under its original name of PT Ivomas Pratama base on notarial deed No.65 of Mrs Maria Kidarsa, S.H, dated on 12 Aug, 1992. The Company’s articles of association has been amended several times, most recently by notarial deed No. 46 of Benny Kristianto, S.H., dated Dec 14, 2010, concerning among others, the change in the Company’s name, par value and public offering.
Read more on SIMP →
